TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

被引：0
|
作者：
Hubin [1 ]
Zhouyujie [1 ]
Liuyuyang [1 ]
Shidongmei [1 ]
Zhaoyingxin [1 ]
Jiadean [1 ]
机构：
[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China
来源：
HEART | 2011年 / 97卷
关键词：
D O I：
10.1136/heartjnl-2011-300867.554
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention
    Li, Yuzhuo
    Li, Jing
    Qiu, Miaohan
    Ma, Sicong
    Na, Kun
    Li, Xiaoying
    Qi, Zizhao
    Chen, Sanbao
    Li, Yi
    Han, Yaling
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 : 1395 - 1402
  • [42] Triple versus Dual Antiplatelet Therapy in Chronic Stable Angina Patients Undergoing Elective Percutaneous Coronary Intervention with Drug-Eluting Stents
    Poddar, Kanhaiya L.
    Rha, Seung-Woon
    Park, Ji Young
    Ramasamy, Sureshkumar
    Wang, Lin
    Choi, Byoung Geol
    Kim, Ji Bak
    Shin, Seung Yong
    Choi, Cheol Ung
    Lim, Hong Euy
    Kim, Jin Won
    Kim, Eung Ju
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Dong Joo
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 110B - 110B
  • [43] Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
    Shih-Chin Chen
    Fei-Yuan Hsiao
    Chii-Ming Lee
    William Wei-Yuan Hsu
    Churn-Shiouh Gau
    [J]. BMC Cardiovascular Disorders, 14
  • [44] Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
    Chen, Shih-Chin
    Hsiao, Fei-Yuan
    Lee, Chii-Ming
    Hsu, William Wei-Yuan
    Gau, Churn-Shiouh
    [J]. BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [45] Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing Percutaneous Coronary Intervention: a the GReek AntiPlatelet registry (GRAPE) substudy
    Hamilos, M.
    Stilianos, S. P. Petousis
    Ioanna, I. X. Xanthopoulou
    Virginia, V. M. Mplani
    Spyros, S. D. Deftereos
    John, J. G. Goudevenos
    Panos, P. V. Vardas
    Dimitrios, D. A. Alexopoulos
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 1382 - 1382
  • [46] Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
    Koziel, Monika
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (03) : 357 - 365
  • [47] Contemporary Antiplatelet Treatment in Acute Coronary Syndrome Patients with Impaired Renal Function Undergoing Percutaneous Coronary Intervention
    Davlouros, Periklis
    Xanthopoulou, Ioanna
    Goudevenos, John
    Hamilos, Michalis
    Vavuranakis, Emmanouil
    Sitafidis, George
    Kanakakis, Ioannis
    Deftereos, Spyridon
    Alexopoulos, Dimitrios
    [J]. CARDIOLOGY, 2017, 138 (03) : 186 - 194
  • [48] Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention
    Roffman, David S.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S18 - S24
  • [49] Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: Economic Considerations
    Weintraub, William S.
    Mandel, Leonid
    Weiss, Sandra A.
    [J]. PHARMACOECONOMICS, 2013, 31 (11) : 959 - 970
  • [50] Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: Economic Considerations
    William S. Weintraub
    Leonid Mandel
    Sandra A. Weiss
    [J]. PharmacoEconomics, 2013, 31 : 959 - 970
12345